XSHG
603585
Market cap477mUSD
Dec 05, Last price
18.07CNY
1D
1.75%
1Q
-2.59%
Jan 2017
-53.34%
IPO
-23.37%
Name
Suli Co Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Suli Co., Ltd. researches, produces, and sells agrochemicals, flame retardants, pharmaceutical intermediates, and other fine chemicals. The company offers chlorothalonil, azoxystrobin, diflubenzuron, fluazinam, cymoxanil, and boscalid technical products; pesticide formulations; and decabromodiphenyl ethane. It also provides brominated, environment-friendly, and halogen-free flame retardants; and intermediates, including trichloroacetonitrile, tetrachlorophthalonitrile, pentachloropyridine, pentachlorobenzonitrile, isophthalodinitrile, and hydrobromic acid, as well as 1,2-diphenylethane and 1,2-dibromoethane. In addition, the company offers industry biocides, such as Longee 985CHL, 550CCD, 550CC, and 500CHL; and ferric chloride solution for use in water treatment. It sells its products under the Suli brand name for use in agricultural production, and plastics and building materials industries, etc. in European Union, North America, South America, Africa, Southeast Asia, and other countries. Suli Co., Ltd. is based in Jiangyin, China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||